BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23474311)

  • 1. Algorithms for identification of Guillain-Barré Syndrome among adolescents in claims databases.
    Funch D; Holick C; Velentgas P; Clifford R; Wahl PM; McMahill-Walraven C; Gladowski P; Platt R; Amato A; Chan KA
    Vaccine; 2013 Apr; 31(16):2075-9. PubMed ID: 23474311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guillain-Barré syndrome following the 2009 pandemic monovalent and seasonal trivalent influenza vaccination campaigns in Spain from 2009 to 2011: outcomes from active surveillance by a neurologist network, and records from a country-wide hospital discharge database.
    Alcalde-Cabero E; Almazán-Isla J; García López FJ; Ara-Callizo JR; Avellanal F; Casasnovas C; Cemillán C; Cuadrado JI; Duarte J; Fernández-Pérez MD; Fernández Ó; Merino JA; Montero RG; Montero D; Pardo J; Rodríguez-Rivera FJ; Ruiz-Tovar M; de Pedro-Cuesta J;
    BMC Neurol; 2016 May; 16():75. PubMed ID: 27206524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating algorithms for identifying incident Guillain-Barré Syndrome in Medicare fee-for-service claims.
    Eiffert SR; Wright B; Nardin J; Howard JF; Traub R
    Glob Epidemiol; 2024 Jun; 7():100145. PubMed ID: 38746856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guillain-Barré syndrome and antecedent cytomegalovirus infection, USA 2009-2015.
    Leung J; Sejvar JJ; Soares J; Lanzieri TM
    Neurol Sci; 2020 Apr; 41(4):885-891. PubMed ID: 31828680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of
    Scallan Walter EJ; Crim SM; Bruce BB; Griffin PM
    Foodborne Pathog Dis; 2020 Jan; 17(1):23-28. PubMed ID: 31509036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of claims-based algorithms for identifying incident thyroid cancer in commercial health plan enrollees receiving antidiabetic drug therapies.
    Funch D; Ross D; Gardstein BM; Norman HS; Sanders LA; Major-Pedersen A; Gydesen H; Dore DD
    BMC Health Serv Res; 2017 May; 17(1):330. PubMed ID: 28476125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of alopecia coding in US claims data among women of childbearing age.
    Schneeweiss MC; Mostaghimi A; Chiuve S; Schneeweiss S; Anand P; Schoder K; Oduol T; Huisingh C; Lin KJ
    Pharmacoepidemiol Drug Saf; 2024 Apr; 33(4):e5782. PubMed ID: 38566351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of validated methods for identifying patients with rheumatoid arthritis using administrative or claims data.
    Chung CP; Rohan P; Krishnaswami S; McPheeters ML
    Vaccine; 2013 Dec; 31 Suppl 10():K41-61. PubMed ID: 24331074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chiari malformation Type I surgery in pediatric patients. Part 1: validation of an ICD-9-CM code search algorithm.
    Ladner TR; Greenberg JK; Guerrero N; Olsen MA; Shannon CN; Yarbrough CK; Piccirillo JF; Anderson RC; Feldstein NA; Wellons JC; Smyth MD; Park TS; Limbrick DD
    J Neurosurg Pediatr; 2016 May; 17(5):519-24. PubMed ID: 26799412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Guillain-Barré syndrome following herpes zoster, United States, 2010-2018.
    Anderson TC; Leung JW; Harpaz R; Dooling KL
    Hum Vaccin Immunother; 2021 Dec; 17(12):5304-5310. PubMed ID: 34856864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guillain-Barré syndrome incidence in a large United States cohort (2000-2009).
    Shui IM; Rett MD; Weintraub E; Marcy M; Amato AA; Sheikh SI; Ho D; Lee GM; Yih WK;
    Neuroepidemiology; 2012; 39(2):109-15. PubMed ID: 22846726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of medical service insurance claims as a surrogate for ascertaining vitiligo cases.
    Bell M; Lui H; Lee TK; Kalia S
    Arch Dermatol Res; 2023 Apr; 315(3):541-550. PubMed ID: 36173455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and clinical characteristics of Guillain-Barré syndrome before the introduction of Zika virus in Puerto Rico.
    Salinas JL; Major CG; Pastula DM; Dirlikov E; Styczynski A; Luciano CA; Wojna V; Sharp TM; Sejvar JJ; Rivera-Garcia B
    J Neurol Sci; 2017 Jun; 377():102-106. PubMed ID: 28477675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation and Evaluation of Guillain-Barré Syndrome Surveillance in Puerto Rico during the 2016 Zika Virus Epidemic.
    Major CG; Dirlikov E; Medina NA; Lugo-Robles R; Matos D; Muñoz-Jordán J; Colón-Sánchez C; García-Negrón M; Olivero-Segarra M; Malavé-González G; Thomas DL; Luciano CA; Waterman SH; Sejvar J; Sharp TM; Rivera-García B
    P R Health Sci J; 2018 Dec; 37(Spec Issue):S85-S92. PubMed ID: 30576584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and prognostic factors of inpatient mortality of Guillain-Barré syndrome: A nationwide population study over 14years in Asian country.
    Liou LS; Chung CH; Wu YT; Tsao CH; Wu YF; Chien WC; Chang CY
    J Neurol Sci; 2016 Oct; 369():159-164. PubMed ID: 27653883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of validated methods for identifying Bell's palsy using administrative or claims data.
    Lee CD; Carnahan RM; McPheeters ML
    Vaccine; 2013 Dec; 31 Suppl 10():K7-11. PubMed ID: 24331076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of validated methods for identifying systemic lupus erythematosus (SLE) using administrative or claims data.
    Moores KG; Sathe NA
    Vaccine; 2013 Dec; 31 Suppl 10():K62-73. PubMed ID: 24331075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of ICD-9-CM codes to identify gastrointestinal perforation events in administrative claims data among hospitalized rheumatoid arthritis patients.
    Curtis JR; Chen SY; Werther W; John A; Johnson DA
    Pharmacoepidemiol Drug Saf; 2011 Nov; 20(11):1150-8. PubMed ID: 22020901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How well do ICD-9 physician claim diagnostic codes identify confirmed pertussis cases in Alberta, Canada? A Canadian Immunization Research Network (CIRN) Study.
    Fathima S; Simmonds KA; Drews SJ; Svenson LW; Kwong JC; Mahmud SM; Quach S; Johnson C; Schwartz KL; Crowcroft NS; Russell ML;
    BMC Health Serv Res; 2017 Jul; 17(1):479. PubMed ID: 28701222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination.
    Velentgas P; Amato AA; Bohn RL; Chan KA; Cochrane T; Funch DP; Dashevsky I; Duddy AL; Gladowski P; Greenberg SA; Kramer JM; McMahill-Walraven C; Nakasato C; Spettell CM; Syat BL; Wahl PM; Walker AM; Zhang F; Brown JS; Platt R
    Pharmacoepidemiol Drug Saf; 2012 Dec; 21(12):1350-8. PubMed ID: 22807266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.